Table 3 Meta-analysis of independent risk factors for MGRS
From: Systematic review and meta-analysis of the clinical features of MGRS
Independent risk factors | Effects model | OR | 95%CI | P-value | Heterogeneity | |
|---|---|---|---|---|---|---|
I2 | P-value | |||||
urinary protein ≥ 1.5 g/d(%) | Fixed | 2.80 | 1.53–5.15 | 0.001 | 0.0 | 0.528 |
abnormal free light chain ratio(%) | Fixed | 6.98 | 4.10-11.91 | <0.001 | 28.4 | 0.237 |
sex(%) | Random | 1.04 | 0.27–4.01 | 0.958 | 81.2 | 0.021 |
hematuria(%) | Random | 1.71 | 0.65–4.52 | 0.275 | 68.7 | 0.074 |
diabetes(%) | Fixed | 0.58 | 0.31–1.07 | 0.081 | 0.0 | 0.687 |